{"id":1068061,"date":"2020-11-02T18:51:20","date_gmt":"2020-11-02T23:51:20","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/nabriva-therapeutics-to-report-third-quarter-2020-financial-results-on-november-5-2020\/"},"modified":"2024-08-18T11:42:28","modified_gmt":"2024-08-18T15:42:28","slug":"nabriva-therapeutics-to-report-third-quarter-2020-financial-results-on-november-5-2020","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/nabriva-therapeutics-to-report-third-quarter-2020-financial-results-on-november-5-2020.php","title":{"rendered":"Nabriva Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020"},"content":{"rendered":"<p><![CDATA[DUBLIN, Ireland, Nov.  02, 2020  (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it will report its third quarter financial results after the close of the U.S. financial markets on Thursday, November 5, 2020. Nabriva\u2019s management will host a conference call at 4:30 p.m. ET to discuss the financial results and recent corporate highlights.]]><\/p>\n<p>See the rest here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/02\/2118793\/0\/en\/Nabriva-Therapeutics-to-Report-Third-Quarter-2020-Financial-Results-on-November-5-2020.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Nabriva Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020\">Nabriva Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>See the rest here: Nabriva Therapeutics to Report Third Quarter 2020 Financial Results on November 5, 2020 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/nabriva-therapeutics-to-report-third-quarter-2020-financial-results-on-november-5-2020.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068061","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068061"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068061"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068061\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068061"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068061"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}